Patent · US Active

Self-destructing transdermal therapeutic system having improved functionality and efficacy

US8435219B2 · kind B2 · utility

0Cited by
3References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 2009
Grant dateMay 7, 2013
Priority date
Expiry dateAug 20, 2029

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB09B2101/68
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a self-destructing transdermal therapeutic system (TTS), preferably in the form of a transdermal patch, that includes an active ingredient, an agent rendering the active ingredient useless, and a perforation mechanism. The perforation mechanism allows a mobile phase to reach an agent that is capable of rendering the active ingredient useless after removing the TTS after use. The agent then comes into contact with the active ingredient and destroys the active ingredient in the presence of the mobile phase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.